Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.95
0.060.3%
Last update: Oct 2, 4:00 PM
$19.95
0.060.3%
Acadia Pharmaceuticals Inc (ACAD) Stock Price, Quote, News & History
ACADNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Acadia Pharmaceuticals (NASDAQ:ACAD) through any online brokerage.
Other companies in Acadia Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Acadia Pharmaceuticals has a consensus price target of $30.82.
The stock price for Acadia Pharmaceuticals (NASDAQ: ACAD) is $19.95 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Acadia Pharmaceuticals.
Acadia Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acadia Pharmaceuticals.
Acadia Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
